Related Experiment Video
Updated: Dec 27, 2025

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
Published on: August 23, 2024
Nanoparticle-Based Delivery of Tumor Suppressor microRNA for Cancer Therapy
Clodagh P O'Neill1, Róisín M Dwyer1,2
1Discipline of Surgery, Lambe Institute for Translational Research, National University of Ireland Galway, Galway, H91 YR71, Ireland.
Abstract:
Improved understanding of microRNA expression and function in cancer has revealed a range of microRNAs that negatively regulate many oncogenic pathways, thus representing potent tumor suppressors. Therapeutic targeting of the expression of these microRNAs to the site of tumors and metastases provides a promising avenue for cancer therapy. To overcome challenges associated with microRNA degradation, transient expression and poor targeting, novel nanoparticles are being developed and employed to shield microRNAs for tumor-targeted delivery. This review focuses on studies describing a variety of both natural and synthetic nanoparticle delivery vehicles that have been engineered for tumor-targeted delivery of tumor suppressor microRNAs in vivo.
Insights
Novel nanoparticles effectively deliver tumor suppressor microRNAs to cancer sites, overcoming delivery challenges for improved cancer therapy. This approach shields microRNAs, enhancing their expression and targeting efficacy in vivo.
Area of Science:
- Oncology
- Molecular Biology
- Biotechnology
Background:
- MicroRNAs (miRNAs) function as tumor suppressors by inhibiting oncogenic pathways.
- Effective delivery of miRNAs to tumors remains a significant challenge in cancer therapy.
Purpose of the Study:
- To review nanoparticle-based delivery systems for tumor suppressor microRNAs.
- To highlight strategies overcoming miRNA degradation, transient expression, and poor targeting.
Main Methods:
- Review of studies on natural and synthetic nanoparticle delivery vehicles.
- Analysis of engineered nanoparticles for targeted delivery of tumor suppressor miRNAs.
Main Results:
- Nanoparticles show promise in shielding miRNAs from degradation.
- Engineered nanoparticles facilitate targeted delivery of miRNAs to tumor sites.
- Both natural and synthetic nanoparticles are being explored for miRNA delivery.
Conclusions:
- Nanoparticle-mediated delivery is a viable strategy for enhancing tumor suppressor miRNA therapy.
- Further development of nanoparticle vehicles is crucial for effective in vivo miRNA delivery.
- Targeted delivery of miRNAs via nanoparticles offers a promising therapeutic avenue for cancer treatment.
More Related Videos
09:02Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
Published on: September 27, 2024
09:06MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as A Novel Detection and Quantification Method
Published on: October 7, 2025
Related Concept Videos
MicroRNAs
MicroRNAs
Experimental RNAi
Targeted Cancer Therapies
There are several types of targeted therapies against...
Drugs that Stabilize Microtubules